Mr. McInerney has 25 years of experience in the investment and pharmaceutical industries and has been a member of the Board of Directors since 2008. He is also the Chairman of the Board’s Nomination and Governance Committee as well as a member of the Board’s Audit Committee. Mr. McInerney is currently a partner with Riverbank Capital Securities, an investment banking firm specializing in biotechnology and specialty pharmaceutical companies.
Related Articles on Ophthalmology:
Acuity Laser Eye and Vision Center’s Dr. Steven Vale: Eye Surgery Should Be Limited to Physicians
Study: Use Grade 2 Reading Level, DVDs for Cataract Surgery Informed Consent
Nanoparticles to Deliver Steroids to the Retina
